Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd 2024 Sustainability Report
Company: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
Sector: Manufacturing
Country: China
Year: 2024
Type: Sustainability Report
Pages: 46
The report describes the company's first reassessment of material ESG issues using double materiality in 2024. It reports 9,873.46 tCO2e of location-based total GHG emissions and a target to reduce GHG emissions intensity by 3% by 2025. The workforce totaled 925 employees at the end of the reporting period.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.